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Cytosolic clearance of replication-deficient
mutants reveals Francisella tularensis interactions
with the autophagic pathway
Audrey Chong,1 Tara D. Wehrly,1 Robert Child,1 Bryan Hansen,2 Seungmin Hwang,3 Herbert W. Virgin3,4 and Jean Celli1,*
Tularemia Pathogenesis Section; Laboratory of Intracellular Parasites; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Hamilton, MT USA;
Electron Microscopy Unit; Research Technologies Branch; Rocky Mountain Laboratories; National Institute of Allergy and Infectious Diseases; National Institutes of Health;
Hamilton, MT USA; 3Department of Pathology and Immunology; University School of Medicine; St. Louis, MO USA; 4Midwest Regional Center of Excellence for Biodefense and
Emerging infectious Diseases Research; Washington University School of Medicine; St. Louis, MO USA
1
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Abbreviations: ATG5, autophagy-related 5; BAF, bafilomycin A1; BMM, murine bone marrow-derived macrophages; Cm,
chloramphenicol; FCV, Francisella-containing vacuole; GFP, green fluorescent protein; LAMP1, lysosomal-associated membrane
protein 1; LC3, microtubule-associated protein 1 light chain 3; MDM, human blood monocyte-derived macrophages; NBR1,
neighbor of BRCA1 gene 1; CALCOCO2/NDP52, nuclear dot protein 52; PI, propidium iodide; SQSTM1/p62, sequestosome 1;
TEM, transmission electron microscopy; Ub, ubiquitin

Cytosolic bacterial pathogens must evade intracellular innate immune recognition and clearance systems such as
autophagy to ensure their survival and proliferation. The intracellular cycle of the bacterium Francisella tularensis is
characterized by rapid phagosomal escape followed by extensive proliferation in the macrophage cytoplasm. Cytosolic
replication, but not phagosomal escape, requires the locus FTT0369c, which encodes the dipA gene (deficient in
intracellular replication A). Here, we show that a replication-deficient, ΔdipA mutant of the prototypical SchuS4 strain is
eventually captured from the cytosol of murine and human macrophages into double-membrane vacuoles displaying
the late endosomal marker, LAMP1, and the autophagy-associated protein, LC3, coinciding with a reduction in viable
intracellular bacteria. Capture of SchuS4ΔdipA was not dipA-specific as other replication-deficient bacteria, such as
chloramphenicol-treated SchuS4 and a purine auxotroph mutant SchuS4ΔpurMCD, were similarly targeted to autophagic
vacuoles. Vacuoles containing replication-deficient bacteria were labeled with ubiquitin and the autophagy receptors
SQSTM1/p62 and NBR1, and their formation was decreased in macrophages from either ATG5-, LC3B- or SQSTM1deficient mice, indicating recognition by the ubiquitin-SQSTM1-LC3 pathway. While a fraction of both the wild-type
and the replication-impaired strains were ubiquitinated and recruited SQSTM1, only the replication-defective strains
progressed to autophagic capture, suggesting that wild-type Francisella interferes with the autophagic cascade. Survival
of replication-deficient strains was not restored in autophagy-deficient macrophages, as these bacteria died in the
cytosol prior to autophagic capture. Collectively, our results demonstrate that replication-impaired strains of Francisella
are cleared by autophagy, while replication-competent bacteria seem to interfere with autophagic recognition, therefore
ensuring survival and proliferation.

Introduction
Bacterial pathogens possess strategies to avoid elimination by
microbicidal mechanisms, while exploiting other cellular processes, in order to survive the inhospitable intracellular environment. Some intracellular pathogens modify the phagosome
into a permissive niche while others physically escape from this
degradative compartment to establish residence in the cytoplasm.1 Phagosome maturation, whereby the pathogen-containing phagosome is progressively transformed into a degradative
compartment via sequential interactions with the endosomal

pathway, has long been recognized to be important in combatting infection.2 Eukaryotic cells also utilize autophagy, initially
described as a cytosolic process to dispose of defunct and/or
surplus organelles and protein aggregates, as a defense mechanism against vacuolar and cytosolic bacterial pathogens including Mycobacterium tuberculosis,3 Salmonella enterica serovar
Typhimurium,4,5 Listeria monocytogenes,6,7 Shigella flexneri8,9 and
Group A Streptococcus pyogenes.10 While autophagy can be a nondiscriminatory process when induced as a homeostatic response,
e.g., by starvation, it is becoming evident that specific cargo can
be selectively targeted to autophagosomes for degradation.11-14
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Recent studies have demonstrated the involvement of ubiquitin and autophagy adaptor proteins, such as SQSTM1/p62
(sequestosome 1), CALCOCO2/NDP52 (nuclear dot protein
52), OPTN/optineurin and NBR1 (neighbor of BRCA1 gene
1) in selectively targeting bacterial pathogens to the autophagy
pathway.15-22 Some pathogens, such as S. flexneri8 and L. monocytogenes,21,23 employ strategies to avoid autophagic recognition,
whereas others, like Coxiella burnetii,24 Legionella pneumophila,25
Staphylococcus aureus,26 and Brucella abortus27 have evolved mechanisms to subvert the autophagy pathway in establishing a replicative compartment, and in the case of B. abortus, to promote
cell-to-cell dissemination.28
Francisella tularensis is a highly infectious, Gram negative,
bacterial pathogen with broad host and cell tropism range.29
Macrophages, however, are an important target for infection and
the bacterium’s virulence is linked to its ability to survive and proliferate within these cells.29-31 Upon internalization, Francisella
initially resides within a phagosome which it rapidly disrupts to
reach the cytosol.32-36 Following extensive replication in the cytosol, bacterial release occurs through macrophage apoptosis37,38
and pyroptosis.39 Additionally, a subset of cytosolic bacteria
can re-enter LAMP1-positive vacuoles, designated Francisellacontaining vacuoles (FCVs), in murine bone marrow-derived
macrophages (BMMs),33 but not in human blood monocytederived macrophages,40,41 via an autophagy-mediated process.
Thus, Francisella has developed multilayered mechanisms to successfully adapt to the different compartments it encounters during its intracellular cycle.
Two critical aspects of Francisella intracellular pathogenesis
are (1) phagosomal escape and (2) cytosolic replication. Mutants
unable to reach the cytosol, such as those with mutations in the
Francisella pathogenicity island genes (e.g., ΔiglC), are defective
for intracellular proliferation and survival.42-47 Mutants that are
specifically impaired for cytosolic replication, such as those with
mutations in purine biosynthesis genes (e.g., ΔpurMCD), are
similarly affected for intracellular survival.39,42,48-50 Recently, we
identified FTT0369c, a locus that was transcriptionally upregulated during the cytosolic stage of F. tularensis subsp tularensis
strain SchuS4 infection of BMMs.42 Deletion of FTT0369c in
SchuS4 did not affect phagosomal escape but impaired cytosolic
replication and intracellular survival.42 Thus, we have re-named
this locus dipA for deficient in intracellular proliferation A. Here,
we report that the SchuS4ΔdipA mutant and other replicationdeficient bacteria are redirected into autophagic vacuoles via the
ubiquitin-SQSTM1-LC3 pathway, as a result of their compromised viability in the macrophage cytosol. By contrast, wild-type
bacteria avoid autophagic recognition and capture, suggesting
that Francisella interferes with the autophagic pathway during
cytosolic proliferation.
Results
Enclosure of cytoplasmic SchuS4ΔdipA bacteria into endocytic
vacuoles. Our previous work has identified dipA as required for
intracellular proliferation and survival of SchuS4 in BMMs.42 In
this study, we sought to further analyze the intracellular fate of a
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ΔdipA in-frame deletion mutant (SchuS4ΔdipA). Compared with
the wild-type SchuS4 strain, which displayed intracellular growth
of 2.5-Log over a 24 h period in BMMs, a SchuS4ΔdipA mutant
did not show intracellular replication (Fig. 1A), as described
previously.42 The lack of replication of the dipA mutant was also
associated with subsequent intracellular killing, since the number
of viable intracellular mutants decreased by 2-Log between 10
and 24 h pi (Fig. 1A). Next, we monitored the vacuolar or cytosolic localization of the mutant bacteria over time. Compared
with a phagosomal escape-deficient mutant (SchuS4ΔfevR)42 of
which no more than 10% was detected as cytoplasmic over a 24 h
period (Fig. 1B), SchuS4ΔdipA escaped from its original phagosome efficiently by 1 h p.i. (84 ± 2.7%; Fig. 1B) and remained
cytoplasmic until 10 h p.i. (94 ± 4.6%; Fig. 1B) similarly to wildtype organisms (98 ± 1.9%; Fig. 1B). Thereafter, the number of
cytoplasmic mutant bacteria decreased with time (72 ± 4.4% at
16 h p.i and 58 ± 1.5% at 24 h p.i.) indicating that a subpopulation of the ΔdipA mutant became enclosed within a vacuolar
compartment (Fig. 1B). Immunostaining of infected BMMs
for the late endosomal/lysosomal marker LAMP1 at 20 h p.i.
showed that a fraction of SchuS4ΔdipA bacteria were surrounded
by LAMP1-positive membranes, indicating enclosure within the
endocytic compartment (Fig. 1C–E).
Previously, we have shown that a subset of wild-type SchuS4
bacteria re-enter LAMP1-positive vacuoles (FCVs) in a replication-dependent manner in BMMs.33 To compare FCV formation by SchuS4 with the endocytic capture of the SchuS4ΔdipA
mutant, we quantified the numbers of infected BMMs harboring bacteria enclosed within LAMP1-positive compartments.
Indeed, we observed that 37 ± 1.7% of SchuS4-infected BMMs
contained clusters of bacteria in LAMP1-positive vacuoles at 20
h p.i. (Fig. 1C and 1E), reflecting FCV formation. Comparably,
38 ± 3.0% of SchuS4ΔdipA-infected BMMs harbored bacteria in
LAMP1-positive vacuoles, suggesting the two vacuolar structures
originate from similar events. Yet, FCV formation requires bacterial replication,33 whereas vacuolar enclosure of the dipA mutant
was associated with a lack of proliferation (Fig. 1A). To determine whether the endosomal vacuoles enclosing the dipA mutant
are distinct from FCVs, we examined whether SchuS4ΔdipA bacteria re-enter the endocytic compartment in human blood monocyte-derived macrophages (MDMs), which do not support FCV
formation by SchuS4.40 In MDMs, SchuS4 grew exponentially
over 24 h whereas the ΔdipA mutant did not proliferate nor survive after 10 h p.i. (Fig. 2A), similar to phenotypes observed in
BMMs (Fig. 1A). First, we quantified the percentage of MDMs
containing bacteria enclosed within LAMP1-positive structures
at 20 h p.i. (Fig. 2B). Few MDMs harbored SchuS4 in LAMP1positive vacuoles (5 ± 1.5%), verifying that FCVs do not develop
in MDMs (Fig. 2B and D). In contrast, 42 ± 1.6% MDMs
contained SchuS4ΔdipA bacteria in LAMP1-positive vacuoles,
consistent with the observations in BMMs, indicating that,
unlike FCVs, enclosure of the dipA mutant within endosomal
vacuoles occurs in MDMs. To refine this analysis, we assessed the
numbers of bacteria that were sequestered in LAMP1 vacuoles
and found that only 1 ± 1.2% of wild-type, but 34 ± 2.5% of
mutant bacteria were contained within LAMP1-positive vacuoles
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(Fig. 2C). Collectively, these findings suggest that enclosure of
the replication-deficient ΔdipA mutant within endocytic vacuoles
is a process distinct from FCV formation.
Vacuolar capture of F. tularensis correlates with replication deficiency. To assess whether capture of SchuS4ΔdipA into
vacuoles resulted from the specific loss of the dipA function or
the consequent inability to replicate in the macrophage cytosol, we examined in BMMs (Fig. 1A and B) and MDMs (Fig.
2A) the intracellular fate of other Francisella strains displaying
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similar cytosolic replication defects, such as SchuS4 treated
with chloramphenicol [SchuS4 (Cm)] and SchuS4ΔpurMCD,
a purine auxotroph mutant capable of phagosome escape but
defective in cytosolic replication.49 Addition of chloramphenicol to wild-type SchuS4 at 6 h p.i. inhibited bacterial replication (Figs. 1A and 2A) at a time point where the majority of
SchuS4 bacteria had escaped into the cytosol (Fig. 1B) and mimicked the intracellular replication defect of SchuS4ΔdipA. Both
chloramphenicol-treated SchuS4 and SchuS4ΔpurMCD bacteria
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Figure 1. Capture of cytosolic Francisella into endosomal vacuoles in BMMs. (A) Intracellular growth of SchuS4, SchuS4 (in 1% FBS-medium), SchuS4
treated with chloramphenicol at 6 h p.i., and its isogenic ΔpurMCD and ΔdipA mutants in BMMs. Intracellular bacteria were enumerated from CFUs
at various times p.i. Data are means ± SD from a representative experiment performed in triplicate out of two independent repeats. (B) Intracellular
trafficking of SchuS4 and its derivatives in BMMs. At various times p.i., infected BMMs were subjected to a phagosomal integrity assay to quantify the
percentage of cytoplasmic bacteria. At least 100 bacteria per experiment were scored for each condition. Data are means ± SD from three independent experiments. (C) Quantification of infected cells containing bacteria enclosed within endosomal vacuoles at 20 h p.i. Infected BMMs were scored
for number of infected cells with bacteria enclosed within LAMP1-positive compartments. At least 100 BMMs per experiment were scored for each
condition. Data are means ± SD from three independent experiments. (D) Quantification of bacteria enclosed within endosomal vacuoles at 20 h p.i.
Infected BMMs were scored for the number of bacteria enclosed within LAMP1-positive compartments. At least 100 BMMs or bacteria per experiment were scored for each condition. Data are means ± SD from three independent experiments. Asterisks indicate statistically significant differences
(**p < 0.01, 1-way ANOVA, Tukey’s post-test). (E) Representative confocal micrographs of BMMs infected for 20 h with either SchuS4 or its derivatives.
Samples were processed for immunofluorescence labeling of bacteria (green) and LAMP1-positive membranes (red). Magnified insets show single
channel images of the boxed areas. White arrows indicate either bacterial clusters or bacteria of interest. Scale bars: 10 or 2 μm.

remained cytoplasmic until 10 h p.i. (Fig. 1B), after which a
fraction of these replication-impaired cytoplasmic bacteria
became re-enclosed within LAMP1-positive vacuoles, similarly
to SchuS4ΔdipA bacteria (Figs. 1C–E and 2B–D). The parallel
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intracellular trafficking among all three replication-deficient
SchuS4 strains suggests that this phenomenon arises from limited bacterial proliferation within the macrophage cytosol, and
not mutation in dipA only.
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Figure 2. Intracellular replication-deficient Francisella are targeted into endosomal vacuoles in human MDMs. (A) Intracellular growth of SchuS4,
SchuS4 (in 1% FBS-medium), SchuS4 treated with chloramphenicol at 6 h p.i., and its isogenic ΔpurMCD and ΔdipA mutants in MDMs. Intracellular
bacteria were enumerated from CFUs at various times p.i. Data are means ± SD from a representative experiment performed in triplicate out of two
independent repeats. (B) Quantification of infected cells containing bacteria enclosed within endosomal vacuoles at 20 h p.i. Infected MDMs were
scored for number of infected cells with bacteria enclosed within LAMP1-positive compartments. At least 100 MDMs per experiment were scored for
each condition. Data are means ± SD from three independent experiments. Asterisks indicate statistically significant differences (**p < 0.01, 1-way
ANOVA, Tukey’s post-test). (C) Quantification of bacteria enclosed within endosomal vacuoles at 20 h p.i. Infected MDMs were scored for the number
of bacteria enclosed within LAMP1-positive compartments. At least 100 bacteria per experiment were scored for each condition. Data are means ± SD
from three independent experiments. Asterisks indicate statistically significant differences (**p < 0.01, 1-way ANOVA, Tukey’s post-test). (D) Representative confocal micrographs of MDMs infected for 20 h with either SchuS4 or its derivatives. Samples were processed for immunofluorescence labeling
of bacteria (green) and LAMP1-positive membranes (red). Magnified insets show single channel images of the boxed areas. White arrows indicate
bacteria of interest. Scale bars: 10 or 2 μm.

Vacuoles sequestering replication-impaired bacteria display features of autophagosomes. Autophagy is a
homeostatic process that directly sequesters cytoplasmic
components for degradation and is also appreciated to
function as a defense mechanism against invading intracellular pathogens.51 Antibacterial autophagy has been demonstrated to target both vacuolar and cytosolic pathogens
for degradation.51 To determine whether vacuolar capture of
replication-deficient SchuS4 is mediated by autophagy, we
first examined LAMP1-positive vacuoles containing replication-impaired bacteria for the presence of the autophagy
marker LC3, in BMMs from GFP-LC3-transgenic mice.
At 20 h p.i., 11 ± 4.0% and 13 ± 4.5% of LAMP1-positive
vacuoles containing chloramphenicol-treated SchuS4 and
SchuS4ΔpurMCD were GFP-LC3-positive, respectively,
whereas a higher proportion of SchuS4ΔdipA bacteria
within LAMP1-positive vacuoles were GFP-LC3-positive
(30 ± 5.6%; Fig. 3A). At 24 h p.i., the levels of GFP-LC3
enriched LAMP1-positive vacuoles containing replicationimpaired bacteria were similar among the three strains (19
± 5.4% SchuS4 (Cm), 17 ± 2.0% SchuS4ΔpurMCD, 18 ±
4.2% SchuS4ΔdipA; Fig. 3A). The varying levels of GFP-LC3
recruitment to LAMP1-positive vacuoles observed among the
different replication-deficient SchuS4 strains suggests differing vacuole maturation kinetics along the autophagic pathway.
Ultrastructural analysis by TEM at 20 h p.i. in BMMs revealed
individual or groups of two or three replication-deficient bacteria
within double-membrane structures resembling autophagosomes
(Fig. 3B), consistent with the observations made by fluorescence
microscopy. Hence, Francisella replication-deficient strains are
captured within vacuoles displaying autophagic features.
Cytosolic detection of F. tularensis by ubiquitin, SQSTM1
and NBR1. To further elucidate the mechanisms of capture of
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replication-deficient Francisella, we next examined how these
bacteria are recognized and targeted to autophagosomes.
Ubiquitination is a well-characterized signal for antibacterial autophagy.5,17,52,53 Ubiquitin-coated bacteria are delivered
to autophagosomes through recruitment of autophagy adaptor
proteins which bind to both ubiquitin and LC3 directly, thus
bridging the two systems.9,15,18,19,21,54 We first examined whether
the replication-deficient strains contained within LC3-positive
vacuoles were labeled with ubiquitin and found that 52 ± 6.1%
of SchuS4(Cm), 71 ± 20.5% of ΔpurMCD and 48 ± 6.9% of
ΔdipA bacteria were ubiquitin-coated at 16 h p.i. (Fig. 4A
and B). Moreover, 76 ± 1.8% of SchuS4(Cm), 81 ± 8.0% of
ΔpurMCD and 82 ± 5.3% of ΔdipA bacteria enclosed within
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Figure 3. Endosomal vacuoles containing replication-deficient
Francisella display features of autophagosomes. (A) Quantification
of GFP-LC3 recruitment to LAMP1-positive vacuoles containing replication-deficient Francisella at 20 h and 24 h p.i. BMMs
expressing GFP-LC3 were infected with either SchuS4 treated with
chloramphenicol at 6 h p.i. or its isogenic ΔpurMCD or ΔdipA mutants, and processed for immunofluorescence labeling of bacteria,
LAMP1-positive membranes and GFP. At least 30 LAMP1-positive
bacteria per experiment were scored for LC3 recruitment in each
condition. Data are means ± SD from three independent experiments. Asterisks indicate statistically significant differences (** p <
0.01, 1-way ANOVA, Tukey’s post-test). (B) Representative confocal
(left panels) and transmission electron (right panels) micrographs
of BMMs infected for 20 h with strains described in (A). Left panels,
BMMs expressing GFP-LC3 were infected and processed for immunofluorescence labeling of bacteria (blue), LAMP1-positive
membranes (red) and GFP (green). Magnified insets show single
channel images of the boxed areas. Empty white arrows indicate
bacteria enclosed within LAMP1-positive, LC3-negative vacuoles;
solid white arrows indicate bacteria enclosed within LAMP1-positive and LC3-positive vacuoles. Right panels, BMMs were infected
and processed for TEM as described in Materials and Methods.
Insets show a magnification of the boxed areas. Black arrows
indicate double membranes surrounding intracellular bacteria.
Scale bars: 10 or 2 μm (confocal images) and 500 or 100 nm (TEM
images).

Figure 5 (see next page). Detection of intracellular Francisella by the macrophage ubiquitin system, SQSTM1 and NBR1. (A and B) Quantification of
(A) ubiquitin- and (B) SQSTM1-decorated bacteria at 16 h p.i. in BMMs. At least 100 bacteria per experiment were scored for colocalization with each
marker in each condition. Data are means ± SD from three independent experiments. (*p < 0.05, 1-way ANOVA, Tukey’s post-test). (C) Quantification
of ubiquitinated bacteria colocalizing with SQSTM1. BMMs were infected for 16 h and processed for immunofluorescence labeling of ubiquitin and
SQSTM1, followed by DAPI staining. At least 30 ubiquitin-positive bacteria per experiment were scored for SQSTM1 recruitment in each condition.
Data are means ± SD from three independent experiments. (D) Representative confocal images of BMMs infected for 16 h with either SchuS4, or its
derivatives. Samples were processed for immunofluorescence labeling of ubiquitinated proteins (red), SQSTM1 (green) and stained with DAPI to label
DNA and intracellular bacteria (blue). Magnified insets show single channel images of the boxed areas. White arrows indicate ubiquitin-positive, p62positive bacteria. Scale bars: 10 or 2 μm. (E) Quantification of NBR1-decorated bacteria at 16 h p.i. in BMMs. At least 100 bacteria per experiment were
scored for NBR1 recruitment in each condition. Data are means ± SD from three independent experiments. (*p < 0.05, 1-way ANOVA, Tukey’s post-test).
(F) Quantification of SQSTM1-positive bacteria that recruit NBR1. BMMs were infected for 16 h and processed for immunofluorescence labeling of
SQSTM1 and NBR1, followed by DAPI staining. At least 30 ubiquitin-positive bacteria per experiment were scored for SQSTM1 recruitment in each condition. Data are means ± SD from three independent experiments. (G) Representative confocal images of BMMs infected for 16 h with either SchuS4,
or its derivatives. Samples were processed for immunofluorescence labeling of SQSTM1 (green), NBR1 (red) and stained with DAPI to label DNA and
intracellular bacteria (blue). Magnified insets show single channel images of the boxed areas. White arrows indicate SQSTM1-positive, NBR1-positive
bacteria. Scale bars: 10 or 2 μm. (H) Quantification of LC3-recruitment to SQSTM1-positive bacteria at 16 h p.i. in BMMs. At least 30 SQSTM1-positive
bacteria per experiment were scored for LC3 recruitment in each condition. Data are means ± SD from three independent experiments. Asterisks
indicate statistically significant differences (***p < 0.001, 1-way ANOVA, Tukey’s post-test). (I) Representative confocal images of BMMs infected for 16
h with SchuS4 and processed for immunofluorescence labeling of SQSTM1 (green) and LC3 (red), and stained with DAPI to label DNA and intracellular
bacteria (blue). Magnified insets show single channel images of the boxed areas. Empty white arrows indicate SQSTM1-positive and LC3-negative
bacteria; solid white arrows indicate SQSTM1-positive bacteria enclosed within LC3-positive vacuoles. Scale bars: 10 or 2 μm.
www.landesbioscience.com

Autophagy

1347

©2012 Landes Bioscience. Do not distribute.

Figure 4. Autophagy-targeted Francisella are tagged with ubiquitin and recruit the autophagy receptor SQSTM1. (A) Quantification of LC3-positive
bacteria colocalizing with ubiquitin (Ub) at 16 h p.i. in BMMs expressing GFP-LC3. At least 30 LC3-positive bacteria per experiment were scored
for ubiquitin colocalization in each condition. Data are means ± SD from three independent experiments. ND, not determined. (B) Representative
confocal images of BMMs expressing GFP-LC3 infected for 16 h with either SchuS4 treated with chloramphenicol at 6 h p.i. or its isogenic ΔpurMCD
or ΔdipA mutants. Samples were processed for immunofluorescence labeling of GFP (green) and ubiquitin (red), and stained with DAPI to label DNA
and intracellular bacteria (blue). Magnified insets show single channel images of the boxed areas. White arrows indicate bacteria of interest. Scale
bars: 10 or 2 μm. (C) Quantification of LC3-positive bacteria displaying SQSTM1 recruitment at 16 h p.i. in BMMs. At least 30 LC3-positive bacteria per
experiment were scored for SQSTM1 colocalization in each condition. Data are means ± SD from three independent experiments. ND, not determined.
(D) Representative confocal images of BMMs infected for 16 h with either SchuS4 treated with chloramphenicol at 6 h p.i. or its isogenic ΔpurMCD or
ΔdipA mutants. Samples were processed for immunofluorescence labeling of LC3 (red) and SQSTM1 (green), and stained with DAPI to label DNA and
intracellular bacteria (blue) at 16 h p.i. Magnified insets show single channel images of the boxed areas. White arrows indicate bacteria of interest.
Scale bars: 10 or 2 μm.

©2012 Landes Bioscience. Do not distribute.
Figure 5. For figure legend, see page 1347.
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LC3-positive vacuoles were also positive for SQSTM1, indicating
a role for this adaptor in the autophagic capture of replicationdeficient SchuS4 (Fig. 4C and D). A fraction of the LC3-positive
bacteria did not colocalize with SQSTM1, suggesting the
involvement of additional adaptors. Unlike the replication-deficient strains, very few wild-type SchuS4 were observed within
LC3-positive compartments (n < 15 per experiment), so we could
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not significantly evaluate the association of SQSTM1
or ubiquitin with such a small population. Nonetheless,
most LC3-positive SchuS4 observed were also labeled
with ubiquitin and SQSTM1 (data not shown), suggesting a similar recognition process. Taken together,
our results indicate that replication-deficient F. tularensis captured within autophagosomes are recognized
by the ubiquitin system and the autophagy receptor
SQSTM1.
To evaluate Francisella detection by ubiquitin and
SQSTM1, we examined the accumulation of these proteins on intracellular bacteria, regardless of their colocalization with LC3-positive structures. Few wild-type
and replication-deficient SchuS4 were decorated with
either ubiquitin or SQSTM1 at 16 h p.i. (< 10%; Fig.
5A and B), indicating that most cytosolic Francisella
are not detected via ubiquitination. Yet ~2-fold more
replication-deficient bacteria than wild-type SchuS4
were associated with SQSTM1 (Fig. 5B), suggesting
an enhanced autophagic recognition of replicationdeficient bacteria. Despite these low numbers, the
majority of ubiquitin-coated bacteria, whether replication-competent or not, colocalized with SQSTM1 (Fig.
5C and D), suggesting that ubiquitinated Francisella
mostly proceed toward recognition by SQSTM1. Due
to the low level recognition by SQSTM1 and because NBR1 possesses functional similarity to SQSTM1,12,13 we also examined
the recruitment of NBR1 to intracellular Francisella and found
similarly few numbers of NBR1-labeled bacteria (Fig. 5E). Yet,
the majority of SQSTM1-positive bacteria were also labeled with
NBR1 (Fig. 5F and G), indicating that both adaptors recognize
the same population of bacteria, consistent with their cooperative
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Figure 6. Vacuolar capture, but not intracellular killing, of
replication-deficient Francisella is dependent on Atg5, Lc3b
and Sqstm1. BMMs were infected with either SchuS4 or its
derivatives, left untreated or treated with 100 nM BAF at 10
h p.i., and processed for immunofluorescence microscopy
at 16 h p.i. (A–D) or enumeration of viable intracellular
bacteria at 24 h p.i. (E–H). (A–D) Quantification of bacteria
within endosomal vacuoles in (A) Atg5flox/flox and Atg5flox/flox Lyz-Cre, (B) C57BL/6 and Lc3b-/-, (C) C57BL/6 and Sqstm1-/-,
or (D) untreated and bafilomycin A1 (BAF)-treated C57BL/6
BMMs. Infection and data analysis of Lc3b-/- (B) and Sqstm1-/(C) BMMs share the same set of C57BL/6 controls because
these experiments were done simultaneously. Samples were
processed for immunofluorescence labeling of bacteria and
LAMP1-positive membranes, and the numbers of bacteria
enclosed within LAMP1-positive compartments were scored.
At least 100 bacteria per experiment were scored for each
condition. Data are means ± SD from three (A and D) or
four (B and C) independent experiments. Asterisks indicate
statistically significant differences (*p < 0.05, **p < 0.01, ***p
< 0.001, two-tailed unpaired Student’s t-test). (E–H) Intracellular survival of SchuS4 or its derivatives in (E) Atg5flox/flox and
Atg5flox/flox -Lyz-Cre, (F) C57BL/6 and Lc3b-/-, (G) C57BL/6 and
Sqstm1-/- or (H) untreated and BAF-treated C57BL/6 BMMs.
Intracellular bacteria were enumerated from CFUs at 24 h
p.i. Data are means ± SD from a representative experiment
performed in triplicate out of two independent repeats.
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autophagosome maturation is inhibited (Fig. 6H), we hypothesized that a significant fraction of these bacteria die in the cytosol
prior to autophagic capture. To test this hypothesis, we designed
a fluorescence microscopy assay based on the membrane-impermeant nucleic acid dye propidium iodide (PI) that specifically
labels either cytosolic or all intracellular bacteria with compromised membranes as an indicator of viability (see Experimental
Procedures). Intracellular killing of 99.9% of cytosolic SchuS4
with tetracycline (Tc, 50 μg/ml for 6 h; data not shown) led to
the detection of 54 ± 1.6% of PI-positive bacteria at 8 h p.i. (Fig.
7A), indicating that about half of Tc-killed bacteria had detectable damaged membranes under our experimental conditions.
Comparatively, ~20% of wild-type and replication-deficient
strains were PI-positive at 8 h p.i. (Fig. 7A), indicating that most
cytosolic bacteria have intact membranes at this stage, yet some
membrane damage occur in a small fraction of cytosolic bacteria, regardless of their replication competency. At 16 h p.i., while
only 13 ± 5.3% of cytosolic SchuS4 were PI-positive, the percentages of PI-positive replication-deficient bacteria ranged from 33
± 4.0% [SchuS4(Cm)] to 47 ± 6.4% (ΔdipA), indicating high
numbers of damaged cytosolic bacteria that are replication deficient (Fig. 7B). This intracellular viability assay may however
underrepresent the percentage of non-viable bacteria, since the
fraction of PI-negative, captured bacteria could also include nonviable organisms whose membranes have not been sufficiently
compromised to be detected by PI staining. Nonetheless, these
results clearly demonstrate that a large fraction of replicationdeficient strains die in the macrophage cytosol between 8 and
16 h p.i.
Since a large fraction of replication-deficient bacteria die in the
macrophage cytosol, we sought to determine whether the macrophage autophagic machinery targeted cytosolic bacteria. Using
SQSTM1 recruitment as a readout of autophagic targeting, we
found that > 75% of SQSTM1-positive bacteria were cytosolic
(Fig. 7C), indicating that not only is autophagy detecting cytosolic Francisella but also that SQSTM1 is recruited directly to the
bacteria rather than to vacuolar membranes. Additionally, about
25% of the cytosolic, SQSTM1-positive bacteria were labeled
with PI (Fig. 7D), indicating that dead cytosolic bacteria are
targeted to autophagy. While the fraction of PI-positive, replication-deficient bacteria within the SQSTM1-positive population
did not vary significantly from that within the cytosolic population (Fig. 7B and D), the SQSTM1-positive SchuS4 population
was enriched in PI-positive bacteria, compared with the whole
cytosolic population (Fig. 7B and D), indicating that damaged
wild-type bacteria are preferentially targeted for autophagic capture. Consistent with the SQSTM1-positive population, 28 ±
6.1% to 46 ± 2.3% of LC3-positive, replication-deficient bacteria
within autophagosomes had compromised membranes (Fig. S2)
and these percentages increased further in the population within
LAMP1-positive, maturing or matured autolysosomes (Fig. S2),
confirming bacterial degradation along the autophagic pathway.
Taken together, our results demonstrate that a large fraction of
replication-deficient Francisella die within the cytosol and are
targeted to autophagy for clearance, which likely accounts for the
limited bactericidal action of the autophagic process.
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function in promoting the capture of ubiquitin-tagged cargo.12
Hence, we used SQSTM1 as a marker of this bacterial population in the remainder of our studies. Interestingly, while the
majority of SQSTM1-positive replication-deficient bacteria also
recruited LC3, consistent with their targeting to autophagic capture, this was not the case of SQSTM1-positive wild-type SchuS4
bacteria, the majority of which did not recruit LC3 (Fig. 5E and
F). Consistent with the near absence of LC3-positive SchuS4
(Fig. 4), this indicates that wild-type Francisella interfere with
the autophagic cascade when targeted for autophagic capture via
ubiquitination and SQSTM1 recruitment.
Capture of replication-impaired bacteria requires ATG5,
LC3B and SQSTM1. Given the autophagic features of the capture process of replication-deficient Francisella, we examined the
functional requirements of the autophagy-associated proteins
SQSTM1, ATG5 and LC3B in the formation of these vacuoles.
BMMs lacking either SQSTM1, ATG5 or LC3B were infected
with either the wild-type or replication-deficient strains and the
percentages of bacteria sequestered within LAMP1-positive vacuoles were quantified at 16 h p.i. Few to no wild-type SchuS4
bacteria were found within LAMP1-positive vacuoles in either
Sqstm1-/-, Atg5f/f-Lyz-Cre, Lc3b-/- or their respective control
BMMs (Fig. 6A–C). In Atg5f/f-Lyz-Cre BMMs, vacuolar recapture of replication-deficient bacteria was considerably diminished
compared with control Atg5f/f BMMs (Fig. 6A), indicating that
this process is dependent upon the autophagy protein ATG5. A
significant reduction in the numbers of replication-deficient bacteria targeted into LAMP1 vacuoles was also observed in both
Lc3b-/- and Sqstm1-/- BMMs compared with control C57BL/6
BMMs (Fig. 6B and C), consistent with the recruitment of these
proteins to replication deficient bacteria (Figs. 3 and 4). Hence,
vacuolar capture of replication-deficient Francisella requires the
canonical autophagy-associated proteins ATG5, LC3B and the
autophagy adaptor SQSTM1.
Given that autophagy is a degradative process, we sought to
examine whether the observed loss of bacterial viability (Figs.
1A and 2A) concomitant with autophagic capture of replicationdeficient strains requires autophagy proteins. To our surprise, the
absence of ATG5 in BMMs did not restore viability of the replication-deficient strains, and had little effect on growth of wild-type
bacteria (Fig. 6E; Fig. S1). The absence of LC3B or SQSTM1 in
BMMs had similarly little effect on the viability of intracellular
bacteria at 24 h p.i. (Fig. 6F and G). Altogether, these results suggest that formation of the autophagic vacuoles does not account
for bacterial killing. Consistently, treatment of infected BMMs
with bafilomycin A1, which blocks autophagosome maturation,55
significantly reduced the numbers of replication-deficient bacteria targeted into LAMP1 vacuoles but did not restore viability of
replication-deficient bacteria at 24 h p.i. (Fig. 6D and H), indicating that autophagosome maturation into degradative autolysosomes does not constitute a significant bactericidal step in the
decreased viability of replication-deficient strains.
Autophagic clearance of replication-deficient Francisella
dying in the macrophage cytosol. To account for the lack of
restored viability of replication-deficient Francisella when
autophagosome formation is decreased (Fig. 6E–G) or
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Figure 7. Survival-impaired Francisella are recognized by SQSTM1 in the macrophage cytosol. (A and B) Quantification of cytosolic bacteria for PI
labeling at 8 h (A) and 16 h (B) p.i. Infected BMMs were either left untreated or treated with tetracycline at 2 h p.i. to kill cytosolic Francisella and then
subjected to an intracellular viability assay to quantify the percentage of dead cytosolic bacteria. At least 100 cytosolic bacteria per experiment were
scored for PI labeling in each condition. Data are means ± SD from three independent experiments. (*p < 0.05, ***p < 0.001, two-tailed unpaired Student’s t-test). (C) Quantification of the percentage of cytosolic SQSTM1-positive bacteria at 16 h p.i. Infected BMMs were subjected to the phagosome
integrity assay, followed by immunofluorescence labeling of SQSTM1. SQSTM1-positive bacteria were scored for vacuolar or cytosolic localization.
At least 30 bacteria per experiment were scored for each condition. Data are means ± SD from three independent experiments. (D) Quantification of
cytosolic SQSTM1-positive bacteria for PI labeling at 16 h p.i. Infected BMMs were subjected to an intracellular viability assay, followed by immunofluorescence labeling of SQSTM1. Cytosolic SQSTM1-positive bacteria were scored for PI labeling. At least 30 bacteria per experiment were scored for
each condition. Data are means ± SD from three independent experiments. (E) Representative confocal images of BMMs infected with either SchuS4
or its derivatives and subjected to an intracellular viability assay at 16 h p.i. Cytosolic bacteria (green) with compromised membranes are labeled with
PI (red) after digitonin permeabilization. All bacteria (blue) are detected after saponin permeabilization. Magnified insets show single channel images
of the boxed areas. White arrows indicate bacteria of interest. Scale bars: 10 or 2 μm. (F) Representative confocal images of BMMs infected for 16 h
with either SchuS4 or its derivatives and processed for an intracellular viability assay followed by immunofluorescence labeling of SQSTM1. SQSTM1positive (green) cytosolic bacteria (blue) with compromised membranes are labeled with PI (red). Magnified insets show single channel images of the
boxed areas. White arrows indicate bacteria of interest. Scale bars: 10 or 2 μm.

Like other cytosol-adapted bacterial pathogens, F. tularensis resides and proliferates for extended lengths of time within
this compartment. With the exception of a belated, autophagymediated response only observed in murine primary macrophages,33 this bacterium dwells in the cytosol without obvious
recognition and capture by the host autophagic machinery, suggesting that it interferes with this process. It has been reported
that Francisella downregulates several genes required for nucleation and elongation of autophagy membranes during infection
of human monocytes,56,57 yet there is so far no direct evidence
that this bacterium inhibits autophagy. We have recently identified a gene, dipA, in the SchuS4 locus FTT0369c, the deletion
of which specifically impairs multiplication in the cytosol.42 By
further characterizing the intracellular fate of a ΔdipA mutant in
an attempt to gain clues about DipA function, we have uncovered
its eventual autophagic capture following a lack of replication.
The possible interpretation that DipA specifically prevents autophagy was, however, ruled out by the similar autophagic capture
of an auxotroph mutant (ΔpurMCD) or the wild-type SchuS4
strain treated with the protein synthesis inhibitor chloramphenicol. While chloramphenicol-treated SchuS4 are likely deficient
in DipA expression, the ΔpurMCD mutant expressed wild-type
levels of this protein (data not shown), yet could not avoid autophagic capture, indicating that DipA deficiency alone is not sufficient for autophagic capture. With the common phenotypes of
these strains being their inability to proliferate in the cytosol,
these results instead indicate that replication deficiency leads to
autophagic capture of Francisella. Consistently, previous work by
Fuller et al. has reported autophagic capture of another, intracellular growth-deficient mutant in the F. tularensis live vaccine
strain (LVSΔripA) at 24 h p.i.,39 lending support to the lack of
gene specificity in this process.
How replication deficiency leads to autophagic capture is
unclear, yet the reduced intracellular viability of all replicationdeficient strains, which resulted in a large part from death in the
macrophage cytosol more than from killing within autolysosomes,
suggests that nonviable Francisella cannot avoid autophagic recognition and capture. While our results highlight autophagy as
a clearance more than a bactericidal process, they also indicate
that either the lack of DipA, a major physiological defect such
as purine auxotrophy, or general inhibition of protein synthesis
affects the viability of Francisella within the macrophage cytosol.
Whether bacteria die due to lethal physiological defects, or via
active killing by macrophage bactericidal mechanisms, remains
to be clarified, although it is conceivable that bacteria with major
physiological defects cannot survive within the macrophage cytosol. The ΔdipA mutant is growth-proficient in rich medium in
vitro,42 but any survival defect under nutrient-limiting and stressinducing conditions similar to those potentially encountered
within the macrophage cytosol needs to be examined.
In investigating the mechanism of autophagy targeting of replication-deficient Francisella, we detected bacterial tagging with
ubiquitin and recruitment of the autophagy receptors SQSTM1
and NBR1. Cargo recognition in antibacterial autophagy is
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not fully understood, yet it clearly involves recruitment of the
autophagy adaptors SQSTM1, CALCOCO2/NDP52, OPTN/
optineurin and NBR1.15,16,18,19,54 While recruitment of other adaptors to ubiquitinated Francisella remains to be examined, the
decreased formation of autophagic vacuoles in SQSTM1-deficient
macrophages and its recruitment to the majority of ubiquitinated
bacteria indicates that SQSTM1 plays a major role in autophagic
recognition of this pathogen, likely in cooperation with NBR1.
Despite a clear involvement of the ubiquitin-SQSTM1-LC3 pathway in Francisella capture, a surprisingly low percentage (~5%)
of all intracellular Francisella were ubiquitinated and recruited
SQSTM1 or NBR1 at any given time (Fig. 5A and B and data
not shown). This could reflect a transient stage of a dynamic
process that rapidly delivers targeted bacteria to the lysosomal
compartment, therefore favoring the detection of later compartments such as LC3- and LAMP1-positive vacuoles. Nonetheless,
the role of ubiquitin- and/or SQSTM1-independent pathway
cannot be ruled out. The involvement of TECPR1, which facilitates ATG12–ATG5 conjugation required for selective autophagy of bacterial pathogens, remains possible, in concert with
the Ub-SQSTM1-LC3 pathway, although whether TECPR1 is
involved in cargo recognition remains unclear.58 It is unlikely,
however, that alternative pathways involving the lipid second messenger diacylglycerol59 and the cytosolic lectin LGALS8/galectin
860 play a role in targeting replication-deficient Francisella, since
these molecules detect damaged vacuolar membranes upon entry
into the cytosol whereas replication-deficient Francisella are captured many hours after phagosomal disruption.
The demonstration of autophagic targeting and capture of
replication-impaired Francisella also provides clues as to how this
pathogen may normally interfere with autophagy to ensure its
successful proliferation in the cytosol. First, the low level of ubiquitin tagging of cytosolic bacteria, whether replication-competent or deficient, suggests that Francisella efficiently avoids such
recognition mechanisms. This is supported by the fact that the
SQSTM1-positive SchuS4 cytosolic population was enriched in
membrane-damaged bacteria (Fig. 7D) in comparison with the
cytosolic population (Fig. 7B), which indicates that autophagy
preferentially targets the few damaged wild-type bacteria. Second,
numbers of wild-type SchuS4 bacteria decorated with ubiquitin
were low and similar to replication-deficient strains (Fig. 5A),
yet fewer wild-type SchuS4 were recognized by SQSTM1 and
NBR1 than replication-impaired bacteria (Fig. 5B and E) and
even fewer of the SQSTM1-associated wild-type SchuS4 progressed to LC3 recruitment (Fig. 5H). Given that SQSTM1 or
NBR1 directly bind to LC3 via their LC3-interacting region
(LIR),11,12 SchuS4 may impair such interactions to block efficient
LC3 recruitment and evade targeting to autophagic membranes.
Hence, in addition to avoiding autophagic recognition in the
cytosol, SchuS4 may also interfere with autophagic capture by
preventing phagophore assembly or elongation, or delivery to
autophagosome membranes. Further studies aimed at dissecting
the molecular mechanisms of autophagy evasion by Francisella
are necessary to confirm our observations, which will not only
shed light on this bacterium’s pathogenic traits, but also on the
molecular events involved in antibacterial autophagy.
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Discussion

Table 1. Primers used in this study
Name

Sequence (5'→ 3')

pJC84 chromosomal detection
JC420

CTA GCT AGC AGG AGA CAT GAA CGA TGA ACA TC

JC427

GGG ACG TCG GAT TCA CCT TTA TGT TGA TAA G

JC428

GGG ACG TCG ATT AAG CAT TGG TAA CTG TCA GAC C

JC589

ATC AGC TCA CTC AAA GGC GG

purMCD deletion
CGG TAC CCG GGG ATC CGA GAG ATT AGC AAC TCA AGT TC

JC966

TAA GCC TGC CAT TTT ATT TCC

JC967

AAA ATG GCA GGC TTA CAG GAG CTT AAA TAA ATA ATG TCT AAG C

JC968

TAT CCA TAC AGT CGA CTA ACT GGT ACA CCT AAT ACT GGT A

JC972

CAG TGT GCT CAG GAG TTG AA

JC973

TTA CTA GGC TTA TCT GAG CA

JC974

GCT GGT AGT AGA ATT ATG GT

JC975

CGC TGG CAT CTG TAC TAT TG

Materials and Methods
Bacterial strains and culture conditions. The prototypic Type A
virulent strain, F. tularensis subsp tularensis SchuS4 was obtained
from Rick Lyons (University of New Mexico, Albuquerque,
NM, USA). The SchuS4ΔdipA (ΔFTT0369c) and SchuS4ΔfevR
(ΔFTT0383) mutants have been described previously.42 Bacteria
were grown on modified Mueller-Hinton (MMH) agar plates
[Mueller-Hinton medium supplemented with 0.1% glucose
(Sigma, G8270), 0.025% ferric pyrophosphate (Sigma Aldrich,
P6526) and 2% IsoVitaleX (Becton Dickinson, 211875)] for 3 d
at 37°C under 7% CO2. For allelic replacement, MMH medium
was supplemented with either 10 μg/ml kanamycin (Sigma,
K0254) or 8% sucrose (Sigma, S9370). All manipulations of
F. tularensis strain SchuS4 and its derivatives were performed
in a Biosafety Level 3 facility according to standard operating procedures approved by the Rocky Mountain Laboratories
Institutional Biosafety Committee.
Construction of an in-frame deletion purMCD mutant of
SchuS4. A SchuS4ΔpurMCD mutant was generated using the
SacB-assisted allelic replacement suicide vector pJC84, as described
previously.42 Deletion of the purMCD (FTT0893-FTT0894) loci
was designed to preserve the integrity of downstream genes and
avoid any polar effects. To engineer an in-frame deletion of purMCD, a 5'-fragment containing 1040 bp upstream of the start
codon of purM (FTT0893), its start and the first 3 codons was
generated by PCR amplification using the primers JC965 and
JC966 and a 3' fragment containing 960 bp downstream of the
stop codon and the last 4 codons of purCD (FTT0984) using
primers JC967 and JC968 (Table 1). Both hemi-fragments were
fused by overlap extension PCR using primers JC965 and JC968.
The resulting 2027 bp fragment containing a residual open reading frame of the first 3 codons of purM and the last 4 codons of
purCD was cloned into the BamHI and SalI sites of pJC84 using
the In-Fusion® PCR Cloning System (Clontech, 639650) and
was fully sequenced.
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To perform allelic replacement in the chromosome of Schu
S4, electrocompetent bacteria were prepared and electroporated
with recombinant pJC84 plasmid DNA as previously described.42
Kanamycin-resistant merodiploid colonies were tested for integration of the allelic replacement plasmid, using colony PCR
with primers JC420 and JC427 (to amplify a 1.5 kb internal fragment of sacB) or JC589 and JC428 (to amplify a 900 bp fragment
of the pJC84 backbone). Independent clones were then subjected
to sucrose counter selection as previously described,42 to isolate
clones that have undergone allelic replacement. The presence of
the deleted allele and allelic replacement within the correct chromosomal locus were verified by PCR using primers JC972 and
JC973 and primers JC974 and JC975 (Table 1) for the purMCD
deletion, and primers JC420 and JC427 for the loss of the sacB
gene. Independent clones with the correct in-frame purMCD
deletion were isolated and used for further studies.
Macrophage culture and infection. Murine bone marrowderived macrophages (BMMs) were harvested from C57BL/6J
(Jackson Laboratories, 000664), Atg5flox/flox and Atg5flox/flox -LyzCre,61 Lc3b-/-62 or Sqstm1-/- 63 and differentiated as described.32
GFP-LC3 transgenic mice were provided by RIKEN BRC
through the National Bio-Resource Project of the MEXT, Japan.
All animal rearing, handling and experimental methods were
conducted under protocols approved by the RML Institutional
Animal Care and Use Committee (IACUC). Human monocytederived macrophages (MDMs) were generated from peripheral
blood monocytes subjected to apheresis and enriched by density
centrifugation using Ficoll-Paque (GE Healthcare, 17-5442-03)
and by negative selection using Dynabeads Untouched Human
Monocytes Kit (Life Technologies, 113.50D) according to the
manufacturer’s instructions. Mononuclear cells were seeded at
a cell density of 2 × 105/well (24-well plate) in RPMI medium
(Life Technologies, 21870) supplemented with 10% fetal bovine
serum (FBS; Life Technologies, 16000-044), 2 mM L-glutamine
(Life Technologies, 25030), nonessential amino acids (Life
Technologies, 11140) and 50 ng/ml recombinant human
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Samples were observed on a Carl Zeiss Axio Imager epi-fluorescence microscope equipped with a Plan-APOCHROMAT
63×/1.4 objective for quantitative analysis, or Carl Zeiss LSM
710 confocal laser scanning microscope for image acquisition.
Confocal images of 1024 × 1024 pixels were acquired and assembled using Adobe Photoshop CS3.
Transmission electron microscopy. Infected BMMs on 12
mm Aclar coverslips were processed as described previously.32
Sections were viewed in a Hitachi H7500 transmission electron
microscope at 80 kV. Images were acquired with a Hamamatsu
2 K × 2 K bottom mount AMT digital camera and assembled in
Adobe Photoshop CS3.
Phagosome integrity assay. To assess the presence and integrity of phagosomal membranes around intracellular F. tularensis,
phagosomal integrity assays were performed as described previously.32 Briefly, infected BMMs were washed three times with
KHM buffer (110 mM potassium acetate, 20 mM Hepes, 2 mM
MgCl2, pH 7.3), the plasma membrane was selectively permeabilized with 50 μg/ml digitonin (Sigma, D141) in KHM buffer
for 1 min at room temperature, immediately washed three times
with KHM buffer and incubated for 12 min at 37°C with rabbit anti-calnexin (specific for the cytoplasmic-facing C-terminal
tail) and Alexa Fluor™ 488-conjugated mouse anti-F. tularensis
LPS antibodies to label the endoplasmic reticulum of permeabilized cells and accessible cytosolic bacteria, respectively. BMMs
were then washed with PBS, fixed with 3% paraformaldehyde
for 20 min at 37°C, and incubated in 50 mM NH4Cl in PBS
to quench free aldehydes. All host cell membranes were permeabilized with 0.1% saponin-10% horse serum in PBS for 30 min
at room temperature. Thereafter, bound anti-calnexin antibodies were detected using cyanin 5-conjugated donkey anti-rabbit
antibodies and all intracellular bacteria were labeled using Alexa
Fluor™ 568-conjugated mouse anti-Francisella antibodies. To
evaluate the intracellular localization of SQSTM1-positive F.
tularensis, infected BMMs were treated as described above with
the following exceptions: Alexa Fluor™ 568-conjugated mouse
anti-F. tularensis LPS antibodies in KHM buffer were used to
detect cytosolic bacteria; following fixation and permeabilization, SQSTM1 was detected using guinea pig anti-SQSTM1 and
Alexa Fluor™ 488-conjugated anti-guinea pig antibodies, and all
intracellular bacteria were labeled using mouse anti-F. tularensis
LPS and Alexa Fluor™ 405-conjugated anti-mouse antibodies.
Samples were observed on a Carl Zeiss Axio Imager epifluorescence microscope equipped with a Plan-APOCHROMAT
63×/1.4 objective for quantitative analysis.
Determination of intracellular bacterial viability. To evaluate
the viability of cytosolic F. tularensis, phagosomal integrity assays
were adapted to allow cytosolic delivery of the cell-impermeant
nucleic acid dye PI. Infected BMMs were incubated for 12 min
at 37°C with Alexa Fluor™ 488-conjugated mouse anti-F. tularensis LPS antibodies and 2.6 μM PI (Life Technologies, L7007)
in KHM buffer to label accessible cytosolic bacteria and compromised bacteria, respectively, in permeabilized cells. Following
fixation and permeabilization of all host cell membranes, all
intracellular bacteria were labeled using mouse anti-Francisella
antibodies and detected using Alexa Fluor™ 405-conjugated
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macrophage colony stimulating factor (M-CSF; PeproTech
Inc., Rocky 300-25). Medium was replenished on day 3 and
day 5 of culture, and MDMs were used for infections on day 6.
Anonymized volunteers provided the human blood cells, after
written informed consent, under protocols approved by the NIH
Clinical Center Institutional Review Board.
Immediately prior to infection of macrophages, a few colonies
from a freshly streaked plate were resuspended in MMH broth
and the OD600nm was measured to estimate bacterial numbers.
Bacteria were diluted to the appropriate multiplicity of infection
(MOI) in either BMM or MDM media and 0.5 ml of bacterial
suspension was added to chilled cells. Macrophage infections
were performed as described32 at an applied MOI of 25 (MDM)
or 50 (BMM). Infections with SchuS4ΔpurMCD and the corresponding control, SchuS4 (1% FBS), were performed in complete
media containing 1% FBS. When required, SchuS4-infected
BMMs were treated with 10 μg/mL chloramphenicol (Sigma,
C1863) at 6 h p.i. or 50 μg/mL tetracycline (Sigma-Aldrich,
87128) at 2 h p.i. Autophagosome maturation was inhibited by
treating BMMs with 100 nM bafilomycin A1 (AG Scientific,
B-1183) at 10 h p.i. and maintained throughout the experiment.
Determination of bacterial intracellular growth. Intracellular
growth of SchuS4 and its derivatives was monitored by determining the number of colony-forming units (CFU) recovered from
lysed macrophages as described previously.32 The number of viable intracellular bacteria per well was determined in triplicate for
each time point.
Fluorescence microscopy. Infected BMMs on 12 mm glass
coverslips were processed for immunofluorescence labeling as
described previously.32 Primary antibodies used were mouse
monoclonal anti-F. tularensis LPS (US Biologicals, F6070-02),
rat monoclonal anti-mouse LAMP1 (clone 1D4B, developed
by J.T. August and obtained from the Developmental Studies
Hybridoma Band; developed under the auspices of the NICHD
and maintained by The University of Iowa, Iowa City, IA), rabbit polyclonal anti-human LAMP1 (Novus Biologicals, NB600956), rabbit polyclonal anti-GFP (Life Technologies, A6455),
mouse monoclonal anti-GFP (Life Technologies, A11120),
mouse monoclonal anti- mono- and poly-ubiquitinylated conjugates (Enzo Life Sciences, PW8810), guinea pig polyclonal
anti-SQSTM1 (Progen Biotechnik, GP62-C), mouse monoclonal anti-NBR1 (AbCam, ab55474) and mouse monoclonal
anti-LC3 (MBL International, M152-3). Secondary antibodies
used were Alexa Fluor™ 488-conjugated goat anti-mouse (Life
Technologies, A11029), Alexa Fluor™ 405-conjugated goat
anti-mouse (Life Technologies, A31553), cyanin-5-conjugated
donkey anti-rabbit (Jackson ImmunoResearch, 711-175-152),
Alexa Fluor™ 568-conjugated goat anti-rat (Life Technologies,
A11077), Alexa Fluor™ 488-conjugated donkey anti-rat (Life
Technologies, A21208), Alexa Fluor™ 568-conjugated goat
anti-rabbit (Life Technologies, A11036), Alexa Fluor™ 488-conjugated goat anti-rabbit (Life Technologies, A11034), Alexa
Fluor™ 488-conjugated goat anti-guinea pig (Life Technologies,
A11073). When required, macrophage nuclei and bacteria were
stained with DAPI (Life Technologies, D3571) for 10 min at
room temperature after incubation with secondary antibodies.
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